It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
www.cnn.com...
US may have to endure social distancing until 2022 if no vaccine is quickly found, scientists predict
science.sciencemag.org...
Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
www.thesun.co.uk...
EUROPE and the US could see up to three more waves of Covid-19 once the virus takes hold in Africa, a global health expert has warned
originally posted by: cirrus12
I didn't see it but apparently Patrick Vallance said that he was sure the r0 was definitely below 1 today at the UK press conference. Seems strange he has that number when we do so little testing here.
Even the WHO say it is between 2 and 3. This paper proposes it's around 5.7
We haven't published any new data as far as I can see - the UK government are really dragging their heels in publishing anything detailed. Or what they base their models on. Frustrating.
originally posted by: RalagaNarHallas
a reply to: Gargoyle91
in Sf they are putting them up in empty hotel rooms www.npr.org...
Local lawmakers in San Francisco have given the mayor 12 days to secure 7,000 hotel rooms to house the city's homeless population during the coronavirus emergency, plus another 1,250 rooms for frontline workers. The emergency ordinance passed by the San Francisco Board of Supervisors requires Mayor London Breed to secure the rooms by April 26 and asks her to use emergency powers to commandeer the rooms if she is unable to reach deals with hotel owners. The vote, taken via videoconference, was a rebuke to what has until now been the mayor's more moderate strategy to place only the city's most vulnerable homeless people in hotel rooms. The legislation highlights the ongoing challenges that San Francisco and other cities face in managing large homeless populations, whose susceptibility to COVID-19 threatens broader efforts to contain the spread of the virus. As of Tuesday, San Francisco had leased about 2,000 hotel rooms but filled less than half of them. It was prioritizing rooms for homeless people older than 60 or those with underlying health conditions that put them at greater risk of death should they contract COVID-19.
The patients taking part in a clinical trial of the drug have all had severe respiratory symptoms and fever, but were able to leave the hospital after less than a week of treatment, STAT quoted the doctor leading the trial as saying.
"The best news is that most of our patients have already been discharged, which is great. We've only had two patients perish," Dr. Kathleen Mullane, an infectious disease specialist at the University of Chicago who is leading the clinical trial, said in the video.
However, the trial does not include what's known as a control group, so it will be difficult to say whether the drug is truly helping patients recover better. With a control arm, some patients do not receive the drug being tested so that doctors can determine whether it's the drug that is really affecting their condition.
Trials of the drug are ongoing at dozens of other clinical centers, as well. Gilead is sponsoring tests of the drug in 2,400 patients with severe Covid-19 symptoms in 152 trial sites around the world. It's also testing the drug in 1,600 patients with moderate symptoms at 169 hospitals and clinics around the world.
I'm sure they can find plenty of places to test besides China.
originally posted by: Byrd
Clinical trial of Remdisivr halted in China because no patients could be recruited. The reason given is " (The epidemic of COVID-19 has been controlled well at present, no eligible patients can be recruitted.)" per the clinical trials site.
The implication is that there's very few new cases -- or that new cases are so widespread that hospitals are seeing only 1-3 of these patients at this time.
There are a total of 11 trials of this drug listed
For fans of zinc and vitamins, there are 5 trials
Can you elaborate on the "ETA: Annnd, nope, doesnt look like it." comment? Did you run across a source about Remdesivir that's worth sharing that prompted that statement?
originally posted by: Serdgiam
a reply to: Willtell
"Things" that inhibit replication of RNA dependent RNA polymerases have a pretty solid body of work. For SARS-CoV, specifically, as well as a surprising amount of efficacy beyond that.
Now, this virus might be a bit different, but case reports worldwide have been quite promising. We shall see if Remdesivir hits whatever numbers they are looking to achieve. I hope it does. ETA: Annnd, nope, doesnt look like it.